Ann: Termination of TLEA Scheme implementation agreement, page-52

First 52 Last

Share
Profile

Follow
Aquarius11

894 Posts.

201

21/04/23

13:03

Post #: 67395654
Share

Originally posted by 2ic: ↑

I'm not trying to embarrass you, but had a quick look at your early posts to get a feel for where you are coming from.

You are obviously a long term holder and believer, not worried about going under water for long periods with your eyes firmly on the distant horizon of development value realisation. Good luck, each to their own, but you can't blame others who don't like holding large positions for long periods with big losses. "selling and giving away their future profits" only happens if the price takes off upwards and doesn;t look back (ie MIN TO offer). If the price falls and others buy back cheaply, then they have avoided losses and increased future profits... yeah?

Anyway, each to their own. Until some news of importance drops I'm going to take my opinion and move on. No interest in going through the coulda, woulda, shoulda... what's done is done, I'll wait to see what happens now from the outside.

GLTAH, cheers.

Expand

Thanks for your contribution 2ic. I hope news does drop soon, and to see you back here for hopefully a good party!

ESS Price at posting: 46.5¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 52 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: Termination of TLEA Scheme implementation agreement, page-52

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News